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Protein kinase C(PKC) is a Ca2+- and phospholipid-dependent protein kinase which can be activated by 
diacylglycerol, a product of polyphosphoinositide hydrolysis. In this report, we show that the polyphosphoi- 
no&ides L-cr-phosphatidylinositol4-monophosphate (PI 4P) and L-a-phosphatidylinositol4,5-diphosphate 
(PI 4,5DP) can serve as phospholipid cofactors of isolated rat brain PKC. The order of potency of the phos- 
phoinositides in the activation of PKC, PI > PI 4P > PI 4,5DP, shows a negative correlation with the 
degree of acidity of the phospholipid head group, whether 1 mM Caz+ or 200 nM TPA is present in the 
reaction assay mixture. Although the polyphosphoinositides are by themselves weaker activators of PKC 
than PI, small amounts of PI 4,5DP cause a two-fold enhancement of PKC in the presence of Ca*+ and 
PI. While the endogenous phospholipid cofactors of PKC remain to be identified, these results suggest hat 
the small amounts of polyphosphoinositides which are present in cell membranes may play a direct role 
in the activation of PKC in vivo, by serving as phospholipid cofactors of the enzyme. 
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1. INTRODUCTION 
Polyphosphoinositides are components of the 
plasma membrane which are metabolized in 
response to certain growth factors, neurotransmit- 
ters, and hormones [1,2]. The hydrolysis of the 
polyphosphoinositide phosphatidylinositol 4,5-di- 
phosphate by phospholipase C catalysis produces 
two second messengers, inositol 1,4,5_triphosphate 
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and diacylglycerol [l-3]. Inositol 1,4,5-triphos- 
phate stimulates the release of Ca2+ from en- 
doplasmic reticulum stores [1,2] and can be 
phosphorylated at the three position, forming in- 
ositol 1,3,4,5_tetraphosphate, which may facilitate 
the entry of calcium ions into cells from the exter- 
nal medium [4,5]. Diacylglycerol activates PKC by 
reducing its requirement for Ca2+ [3]. PKC is a 
Ca2+- and phospholipid-dependent protein kinase 
which catalyzes the phosphorylation of proteins at 
serine and threonine residues [3]. PKC catalyzes 
the phosphorylation of the enzyme inositol 1,4,5- 
triphosphate 5 ’ -phosphomonoesterase, thereby 
activating it and facilitating the degradation of in- 
ositol 1,4,5_triphosphate [6]. The activation of 
PKC requires an acidic phospholipid cofactor such 
as PS or PI, although certain fatty acids can also 
fulfill the lipid cofactor requirement of the enzyme 
[7]. Thus, the signal transduction pathway which 
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includes the activation of PKC by diacylglycerol 
also involves the catabolism and resynthesis of 
potential phospholipid cofactors of PKC, i.e. PI 
and its polyphosphorylated erivatives. 
In this report, we have examined the direct ef- 
fects that the polyphosphoinositides PI 4,5DP and 
PI 4P have on isolated rat brain PKC. We have 
determined the capacities of PI 4P and PI 4,5DP 
to serve as phospholipid cofactors of PKC, and the 
effects of variations in the relative concentrations 
of PI and polyphosphoinositides on PKC activity. 
2. MATERIALS AND METHODS 
2.1. Materials 
[Y-~~P]ATP was purchased from Amersham 
(Arlington Heights, IL), Hydrofluor was from Na- 
tional Diagnostics (Somerville, NJ), and 
phosphocellulose paper was from Whatman (Clif- 
ton, NJ). ATP, PMSF, PS, PI, PI 4P, PI 4,5DP, 
Tris-HCl and histone 111s were purchased from 
Sigma (St. Louis, MO). TPA was purchased from 
LC Services (Schaumburg, IL). Leupeptin was a 
gift of the US-Japan Cooperative Cancer Research 
Program. 
2.2. Methods 
Rat brain PKC was partially purified as de- 
scribed [8] and then chromatographed on a second 
DEAE Sephacel column with a linear gradient of 
0 to 0.3 M NaCl. The resultant PKC preparation 
had a specific activity of 230 nmol 32P/min per mg 
and was activated from lo- to 30-fold by 1 mM 
Ca2+ plus 80 pg PS/ml and by 200 nM TPA plus 
8Opg PS/ml. PKC was assayed as described [8], by 
measuring the Ca’+- and phospholipid-dependent 
phosphotransferase reaction between [Y-~~P]ATP 
and histone HIS, in a reaction mixture containing 
20 mM Tris-HCl at pH 7.5, 5 mM 2-mercapto- 
ethanol, 10 mM MgC12, 1 mM CaCl2 (or 1 mM 
EGTA), 80 pug PS/ml (or indicated amounts of the 
specified phospholipid), 70 PM [Y-~~P]ATP 
(250-400 cpm/pm), 0.67 mg histone IIIS/ml and 
l-4 fig rat brain PKC. Reactions were initiated by 
the addition of PKC. The reactions proceeded at 
30°C and were terminated after 5-10 min (i.e., 
during the linear phase of the phosphotransferase 
reaction) on phosphocellulose paper. The radio- 
activity incorporated into histone was determined 
as described [8]. The Ca’+- and phospholipid- 
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dependent phosphotransferase activity of PKC 
was calculated by subtracting the activity observed 
in the absence of Ca2+ and phospholipid from the 
activity observed in the presence of these cofac- 
tors. The TPA-dependent activation of PKC was 
measured by substituting 200 nM TPA plus 1 mM 
EGTA for 1 mM Ca’+. TPA in the presence of 
EGTA has been shown to substitute completely for 
added Ca2+ in the activation of PKC [8-lo]. 
In order to prepare phospholipid stock solu- 
tions, phospholipids were dried under nitrogen for 
the removal of chloroform, resuspended in water 
by vortexing, and sonicated for 1 min on ice. Stock 
solutions of TPA (1 mg/ml) were made up in 
DMSO and stored at -20°C. 
3. RESULTS 
Fig.1 illustrates the relative capacities of PI, PI 
4P and PI 4,5DP to activate PKC in the presence 
of 1 mM Ca2+ . While all three compounds ac- 
tivated PKC under these conditions, it is clear that 
the activation potencies of the polyphospho- 
inositides were significantly weaker than that of 
PI, throughout a range of phospholipid concentra- 
tions from 1 pug/ml to 500 pg/ml. PI 4,5DP was 
Fig. 1. The Ca’+-dependent activation of PKC by PI, 
PI 4P and PI 4,5DP. PKC activity was assayed as 
described in section 2.2, in the presence of 1 mM CaZC 
and the indicated phospholipid. ‘% activation of PKC’ 
represents the percentage of activation of PKC relative 
to that observed in the presence of 1 mM Ca2+ and 
2OOpg PS/ml. The latter condition produced maximal 
activity and, therefore represents the 100% value. Its 
actual value was 230 k 9 nmol 32P transferred/min per 
mg. (o)PI, (0) PI 4P and (A) PI 4,5DP. 
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substantially weaker than PI 4P as a PKC cofactor 
at phospholipid concentrations of l-10 ,ug/ml, 
although at higher phospholipid concentrations PI 
4,5DP and PI 4P activated PKC with similar ef- 
ficacies. Thus the relative potencies of PI, PI 4P 
and PI 4,5DP in the activation of PKC in the 
presence of Ca2+ correlated with the degree to 
which each phospholipid was phosphorylated, 
with the most potent PKC phospholipid cofactor 
being the least phosphorylated. 
In order to investigate whether the potencies of 
the polyphosphoinositides in the activation of 
PKC were lower than that of PI due to Ca2+ chela- 
tion by the anionic phosphate groups of the 
polyphosphoinositides, we examined the activation 
of PKC by these phospholipids in the presence of 
200 nM TPA and 1 mM EGTA. Previous reports 
have indicated that the phorbol ester TPA can 
completely overcome the requirement for added 
Ca2+ in the in vitro activation of PKC [&lo]. 
Fig.2 shows that the relative potencies of PI and 
the polyphosphoinositides in the TPA- and 
phospholipid-mediated activation of PKC were 
PI > PI 4P > PI 4,5DP, over a range of 
phospholipid concentrations from 1 ,ug/ml to 
50 pg/ml. PI was a more potent PKC phospholipid 
cofactor than either polyphosphoinositide at all 
phospholipid concentrations tested (I-500 pg/ml 
phospholipid). Thus the relative capacities of PI 
and the polyphosphoinositides to activate PKC 
were similar whether the enzyme was under the 
regulation of Ca2+ and phospholipid or TPA and 
phospholipid, providing strong evidence that the 
relative potencies which were observed in the Ca’+- 
and phospholipid-dependent reaction do not simp- 
ly reflect Ca2+ chelation by the polyphos- 
phoinositides. 
Figs 1 and 2 clearly indicate that PI 4,5DP is a 
much weaker phospholipid cofactor for PKC than 
is PI. Since PI 4,5DP is a minor constituent of cell 
membranes relative to PI [l], we next examined 
whether low concentrations of PI 4,5DP might 
modify the activation of PKC by PI. Table 1 shows 
that 1 pug PI 4,5DP/ml, which by itself had negligi- 
ble effects on PKC activity in the presence of Ca2+ 
(fig.l), caused an almost 2-fold enhancement of 
the activation of PKC by 1 mM Ca2+ and 10 yg/ml 
PI. Similar enhancements of the Ca’+- and PI- 
dependent activation of PKC were observed with 
5 pg and 1Opg PI 4,5DP/ml (table 1). Table 2 
shows that, at concentrations of l-1Opg PI 
4P/ml, PI 4P also enhanced the activation of PKC 
by 1 mM Ca2+ and 1Opg PI/ml. However, PI 4P 
was weaker than PI 4,5DP in the enhancement of 
the Ca2+- and PI-dependent activity of the enzyme. 
Fig.2. The TPA-dependent activation of PKC by PI, PI 
4P and PI 4,5DP. PKC activity was assayed as described 
in section 2.2, in the presence of 200 nM TPA plus 
1 mM EGTA and the indicated phospholipid. ‘% 
activation of PKC’ represents the percentage of 
activation of PKC relative to that observed in the 
presence of 200 nM TPA and 200/g PS/ml. In this 
experiment the latter value was 300 + 4 nmol 32P 
transferred/min per mg. (0) PI, (0) PI 4P and (A) 
PI 4,5DP. 
Table 1 
The enhancement of the Ca’+- and PI-dependent 
activity of PKC by PI 4,5DP 
pg PI 4,5DP/ pm01 32P/ Fold-enhancement of 
ml min PKC activity 
0 12 * 1 1.0 
1 23 + 1 1.9 
5 25 -t 1 2.0 
10 26 -t 1 2.2 
Ca’+- and PI-dependent PKC activity was measured as 
described in section 2.2 in the presence of 1 mM Ca2+ 
and 10/g PI/ml. The effects of PI 4,5DP on the Ca2+- 
and PI-dependent activity of PKC were determined by 
including the indicated amounts of PI 4,5DP in the PKC 
assay mixtures 
341 
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Table 2 
The enhancement of the Ca2+- and PI-dependent 
activity of PKC by PI 4P 
,Ug PI 4P/ pm01 32P/ Fold-enhancement 
ml (activity) min of PKC 
0 15 -t 1 1.0 
1 20 * 2 1.3 
5 25 + 1 1.7 
10 23 k 1 1.5 
Ca’+- and PI-dependent PKC activity was measured as 
described in section 2.2 in the presence of 1 mM Ca2+ 
and 10 pg PI/ml. The effects of PI 4P on the Ca2+- and 
PI-dependent activity of PKC were determined by 
including the indicated amounts of PI 4P in the PKC 
assay mixtures 
4. DISCUSSION 
Polyphosphoinositide hydrolysis occurs in 
response to the interactions of certain growth fac- 
tors, neurotransmitters and hormones with their 
receptors and results in the production of 
diacylglycerol, an activator of PKC [l-3]. Since 
PKC is activated by acidic phospholipids [7] and 
since polyphosphoinositides are acidic phospho- 
lipids whose metabolism is intimately linked with 
the in vivo activation of PKC [l-3], it is important 
to characterize direct effects of the 
polyphosphoinositides on PKC activity. In this 
report, we show that PI 4P and PI 4,5DP can, in 
fact, activate isolated PKC, although at optimal 
concentrations they are only about one-third to 
one-half as potent as PI. The order of potency of 
the phosphoinositides in the activation of PKC (PI 
> PI 4P > PI 4,5DP) shows a negative correlation 
with respect to the degree of phosphorylation of 
the lipids. The capacity of each of these lipids to 
serve as a PKC cofactor is similar whether 1 mM 
Ca*+ or 200 nM TPA plus 1 mM EGTA is present, 
demonstrating that the reduced capacity of 
polyphosphoinositides to activate PKC is not 
simply a consequence of Ca2+ chelation by the 
phosphorylated head group of the lipid. Thus, the 
capacities of these phospholipids to serve as PKC 
substrates appear to be greatly affected by the 
acidity of their head groups. 
Although PS is the most effective of the known 
phospholipid activators of isolated PKC [7], it is 
not clear at this time which phospholipids are im- 
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portant in the activation of PKC in vivo. 
Presumably, in intact cells PKC is activated by 
association with cell membranes which have a very 
complex composition. In most cells, polyphospho- 
inositides comprise lo-20% of the inositol lipids 
[ 11. In this report, we found that the polyphospho- 
inositide PI 4,5DP was a weak PKC activator in 
the absence of other phospholipids, but a minor 
amount of it, which by itself had negligible effects 
on PKC activity, caused a 2-fold enhancement of 
the activation of isolated PKC by 1 mM Ca2+ and 
1Opg PI/ml. Thus, in our in vitro system, when 
the phospholipid composition was about 10% PI 
4,5DP and 90% PI, the activation of PKC was 
2-fold greater than that obtained with PI alone. PI 
4P enhanced the activity of the enzyme in a similar 
fashion, although to a lesser extent. While the en- 
dogenous phospholipid cofactors of PKC remain 
to be identified, these results suggest that the 
minor amounts of PI 4,5DP and PI 4P which are 
present in the cell membranes may play a direct 
role in the activation of PKC in vivo, by serving as 
phospholipid cofactors for the enzyme. 
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